Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
Vactosertib, ALK5 inhibitor combinatorial treatment with radiation inhibits lung metastasis in syngeneic breast mouse models
Joint Event on 6th World Congress and Expo on Breast Pathology and Cancer Diagnosis & 20th International Conference on Medicinal Chemistry and Rational Drugs
Radio-resistance and relapse after chemotherapy is a life-threatening problem for breast cancer patients. We identified the
molecular signatures of the recurrent breast cancer patients after radiotherapy, which showed the up-regulation of TGF-�²
signaling and the epithelial-to-mesenchymal transition (EMT). In order to find the potential therapeutic strategies to improve
radiation therapy, we conducted gene set enrichment analysis, a computational method that determines whether an a priori
defined gene set shows statistically significant between two phenotypes, using the breast cancer clinical data with Servant
cohort (GSE30682). Since we have proved that EW-7197 showed the inhibitory effect in vivo in various breast cancer mouse
models previously, we carried out experiments that might test if combinatorial treatment of EW-7197 improves radiation
therapy using two syngeneic mouse models. Met 1 cell, which are derived from primary tumors of the FVB/N transgenic
mouse with mammary tumor-polyoma virus middle T antigen (MMTV-PyVmt), were injected to fourth inguinal fat pads of
FVB/N mice. 4T1 cells, which are derived from primary tumors of Balb/c mice, were injected as same way into Balb/c mice. Mice were
treated with the fractionated-radiation (total dose 12 Gy, 4 Gy X3) with or without the combinatorial treatment of EW-7197 (2.5 mg/kg).
Conclusion & Significance: Vactosertib (EW-7197), ALK5 inhibitor combinatorial treatment with radiation inhibits tumor
growth and metastasis in syngeneic breast mouse models. This effect of Vactosertib (EW-7197), ALK5 inhibitor combinatorial
treatment with radiation inhibits tumor growth and metastasis in syngeneic breast mouse models. Vactosertib (EW-7197)
maybe related to the breast cancer stem-like phenotype, which is increased by 4Gy irradiation in vitro. We need to further
study to conclude the therapeutic mechanisms of EW-7197 on improving radiation therapy. This work was supported by the
National Research Foundation of Korea grant funded by the Korea government (NRF-2015M2A2A7A01041499) and (NRF-
2014R1A1A2005644).
Biography
Yhun Sheen has her research interest in developing new anti-cancer drug. She had participated in the development of TEW-7197 which is currently under clinical trial in USA (NCT02160106).